Geo News
Community curated by people like you
LatestAICryptoHealthWorld AffairsUS Politics
Publicis Groupe Acquires LiveRamp for $2.2 Billion to Expand AI Capabilities
00

Publicis Groupe Acquires LiveRamp for $2.2 Billion to Expand AI Capabilities

May 18, 2026

Publicis Groupe agreed to acquire US data company LiveRamp for $2.2 billion in an all-cash transaction. The deal values LiveRamp at $38.50 per share, nearly 30% above its May 15, 2026 closing price. The acquisition will enhance Publicis Groupe's ability to offer AI-driven marketing services as the French advertising giant deepens its investment in artificial intelligence infrastructure.

LiveRamp acquisition details

  • ▪Publicis Groupe is a French advertising company
  • ▪The LiveRamp acquisition takeover price is $38.50 per share
  • ▪Publicis Groupe agreed to acquire LiveRamp for $2.2 billion
  • ▪The LiveRamp acquisition price represents nearly 30% above LiveRamp's closing price on May 15, 2026
  • ▪The Publicis Groupe acquisition of LiveRamp is an all-cash transaction
  • ▪LiveRamp is a US-based data company

AI-driven marketing expansion

  • ▪The LiveRamp acquisition will enhance Publicis Groupe's ability to offer AI-driven marketing services
  • ▪Publicis Groupe is deepening its investment in artificial intelligence-driven marketing through the LiveRamp acquisition

1 source

Cryptopolitan
Publicis Groupe expands AI ambitions with $2.2B LiveRamp buyout
View source article

Featured stories

View more in Data infrastructure

Databricks acquires Row Zero to bring spreadsheets to Genie platform

Sep 24, 2026 · 3 sources

Enveda raises $311M at $2B valuation for AI-powered natural drug discovery

Sep 23, 2026 · 2 sources

Story comments

Loading comments…

Related entities

United StatesFrance

Topics

Data infrastructureMergers & acquisitions (M&A)AI for developers

Featured stories

View more in Data infrastructure

Databricks acquires Row Zero to bring spreadsheets to Genie platform

Sep 24, 2026 · 3 sources

Enveda raises $311M at $2B valuation for AI-powered natural drug discovery

Sep 23, 2026 · 2 sources